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The responses of each country were researched and studied to isolate any key 
actions that impacted the rate of spread of the virus, including, but not limited to, first 
case date, number of tests per case, percent of positive tests, local and national 
mandates description and dates, and contact tracing.
Prior research articles were considered and analyzed to explore and discover 
the relation between COVID-19 and other factors that could significantly increase 
the severity and mortality of the disease. 
Data was obtained from JHU and IHME databases. The data for confirmed 
cases was then imported and standardized using MATLAB through the following 
mathematical equation:
𝑁𝐶𝐶 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝐶𝑎𝑠𝑒𝑠
𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
∗ 100,000
Data for confirmed deaths, from COVID-19, and identified factors, was 
standardized using a similar mathematical equation:
𝑁𝐶𝐷 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝐷𝑒𝑎𝑡ℎ𝑠
𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
∗ 100,000
The line graphs were created using the plot function. The bar graphs were created 
using the bar function. Graph titles were added using the title function. Axis labels 
were added using the xlabel and ylabel functions for the x-axis and y-axis, 
respectively. The size of graphs 1 and 2 had to be modified using gca or current axes. 
The font was increased and bolded for graphs 3 and 4 using gcf or current graph 
handle. The legends were added using the legend function. For graphs 3 and 4, the 
legends had to be altered to horizontal orientation using the legend function. 
Late December 2019, a coronavirus disease (COVID-19) was 
identified in Wuhan, China. COVID-19 was a result of the novel severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2), which has resulted in a 
worldwide sudden and substantial increase in hospitalizations for pneumonia 
with multiorgan disease. As of October 6, 2020, SARS-CoV-2 has affected 
more than 200 countries, resulting in more than 35 million identified cases 
with more than 1 million confirmed deaths. 
This is a cross-sectional, non-interventional, observational study in 
patients infected with the novel coronavirus (SARS-CoV-2) or Covid-19, 
using the John Hopkins University (JHU) Coronavirus database, and Institute 
for Health Metrics and Evaluation (IHME) database. The data collected from 
the JHU Coronavirus database and IHME database will be used to create a 
MATLAB program, which will produce graphs with standardized data that 
will be used to investigate, describe and compare the circumstances during 
the past year in the US and the EU5 (UK, Germany, France, Italy and Spain). 
The experiment compared the number of confirmed cases and confirmed 
deaths because of the Covid-19 disease. Furthermore, the experiment 
compared each country’s deaths from non-communicable diseases (NCDs), 
smoking, and obesity. The experiment found the most important risk factors 
and comorbidities associated with mortality of patients infected by COVID-
19. 
The countries chosen were picked based on the following facts:
• All 6 Countries are considered high-income countries
• The EU5 have a public healthcare system versus the private healthcare 
system in the US
• All 6 countries have similar education and health literacy level
• All 6 countries had the first COVID-19 case during January 2020
• All 6 countries are a popular hub for travelers and tourists
If proven successful, this project can identify some of the factors that 
increase the severity and mortality of the disease among the discussed 
countries, and in turn shine a light on some of the areas where healthcare 
services and public education need improvement. 
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Graph 1
• US never flattened the curve, unlike European 
countries between May and August 2020
• US maintained the highest number of confirmed cases 
per 100,000 since June 2020
• Germany maintained the lowest number of confirmed 
cases per 100,000 since April 2020
• Number of case in Europe (except Germany) began 
rising exponentially towards the end of the summer 
2020
• Spain and France are nearing the US’s number of 
cases per 100,000 and are rising at a steeper rate
• Germany didn’t rise until October, unlike other 
European Countries, but still had the overall lowest 
number of cases per 100,000
Graph 2
• Number of confirmed deaths per 100,000 in the US 
maintained a semi-constant rate of increase from 
April to November 2020
• Spain predominantly maintained the highest number 
of confirmed deaths per 100,000 since April 2020
• Germany maintained the lowest number of 
confirmed deaths per 100,000 since April
• Number of deaths in Europe (except Germany) 
began rising exponentially towards the end of the 
summer 2020 
• European countries (except Germany) had a semi-
vertical rise in confirmed deaths per 100,000 
between March and April 2020
Graph 3 (2019)
• Germany has the highest number of deaths per 
100,000 from Cardiovascular disease (CVD), 
Neoplasms (Cancers), and Chronic Kidney disease 
(CKD)
• Italy has the highest number of deaths per 100,000 
from Diabetes Mellitus (DM)
• Spain has the highest number of deaths per 100,000 
from Chronic Obstructive Pulmonary Disease 
(COPD)
• France has the lowest number of deaths per 100,000 
from CVD and COPD
• US has the lowest number of deaths per 100,000 
from Neoplasms
• UK has the lowest number of deaths per 100,000 
from DM and CKD
Graph 4 (2019)
• US has the highest number of deaths from smoking 
per 100,000
• US has a significantly higher number of deaths 
caused by obesity (>30 Body Mass Index [BMI]) 
per 100,000
• France has the lowest number of deaths per 100,000 
caused by obesity
• Italy has the lowest number of deaths per 100,000 
caused by smoking
Germany has the highest number of deaths per 100,000 
for 3 NCDs and 2nd highest number of deaths per 
100,000 caused by obesity and smoking
All the concluding statements are only regarding the discussed 
countries.
The risk factors and comorbidities found to increase the severity 
and mortality of COVID-19 were as follows: Cardiovascular Disease, 
Neoplasms, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, 
Chronic Kidney Disease, Obesity (>30 BMI), Smoking, and old age (65+).
In conclusion, Germany was the most successful in minimizing the 
number of cases and deaths from COVID-19 per 100,000, even though the 
country leads in deaths per 100,000 from 3 NCDs, second to the US in 
smoking and obesity related deaths per 100,000, and 21.1% of the 
population is above 65 years old. On the contrary, Spain was the least 
successful in terms of the number of deaths from COVID-19 per 100,000. 
The US was the least successful in controlling the spread of the virus as they 
have predominantly maintained the highest number of cases of COVID-19 
per 100,000. 
Germany was early and efficient in beginning to prevent the spread 
of the virus. “Robert Koch Institute (RKI) and scientists at other institutions 
mobilized in early January to launch national crisis management to 
understand the epidemiology of the pandemic.”1 Furthermore, Germany 
continued in its success to detect the virus as they were one of the very first 
countries to develop a diagnostic test for COVID-19 and have conducted 
rigorous contact tracing. Moreover, Germany’s government worked along 
public and private laboratories to maximize the potential and efficiency for 
testing. Another aspect Germany was successful in, with regards to the 
spread of the virus, was limiting the transmission in long-term care 
establishments, which led to a significantly lower number of cases among 
the older population, further lowering the case-fatality rate. Finally, 
Germany has the highest number of hospital beds per 10,000 (80.0) and with 
careful planning alongside educated actions, the healthcare system did not 
become overstressed, allowing for continuous treatment for all severely 
affected cases.
Spain maintained the highest number of deaths per 100,000 caused 
by COVID-19 since April 2020. Spain exercised an extremely strict national 
lockdown from March 14th till May 9th, 2020. Unlike its neighboring 
countries to the east, Spain has a significantly lower number of hospital beds 
per 100,000 (29.7) (France: 59.8). “The first HCW infected was confirmed 
on March 9th. A total of 791 HCW and personnel were confirmed to be 
infected by March 29th, representing 38% of those tested and 11,6 % of all 
the hospital workers.” 2
US maintained a steady increase in the number of COVID-19 cases 
per 100,000 and currently hold the highest number of cases worldwide. 
Unlike its European counterparts, the US never flattened the curve. 
Furthermore, the US federal government failed to devise a national strategy 
to lead, direct, and support the states. Overall, the US response was 
primarily on a state level only, with only a few states enacting state level         
lockdowns.
